Avanos Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Avanos Medical
AVNS Stock  USD 11.73  0.42  3.71%   
Avanos Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Avanos Medical's valuation are provided below:
Gross Profit
365.9 M
Profit Margin
(0.67)
Market Capitalization
544.5 M
Enterprise Value Revenue
0.8404
Revenue
699.9 M
There are over one hundred nineteen available fundamental signals for Avanos Medical, which can be analyzed over time and compared to other ratios. All traders should validate Avanos Medical's prevailing fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction. Enterprise Value is likely to gain to about 2.3 B in 2026, whereas Market Cap is likely to drop slightly above 1.4 B in 2026.

Avanos Medical Total Revenue

817.15 Million

Check Avanos Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Avanos Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 39.5 M, Interest Expense of 15.9 M or Selling General Administrative of 284 M, as well as many indicators such as Price To Sales Ratio of 1.58, Dividend Yield of 0.26 or PTB Ratio of 1.42. Avanos financial statements analysis is a perfect complement when working with Avanos Medical Valuation or Volatility modules.
  
Build AI portfolio with Avanos Stock
Check out the analysis of Avanos Medical Correlation against competitors.
For more information on how to buy Avanos Stock please use our How to Invest in Avanos Medical guide.

Avanos Medical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding51.7 M52.9 M47.6 M
Slightly volatile
Short and Long Term Debt Total254 M153.2 M275.7 M
Very volatile
Property Plant And Equipment Net175.2 M130.3 M223.7 M
Slightly volatile
Non Current Assets Total1.1 B684.7 M1.4 B
Slightly volatile
Non Currrent Assets Other28 M26.7 M12.7 M
Slightly volatile
Cash And Short Term Investments156.3 M123.9 M130.7 M
Slightly volatile
Liabilities And Stockholders Equity1.6 B1 B1.9 B
Slightly volatile
Non Current Liabilities Total275.9 M143.8 M302.5 M
Very volatile
Property Plant And Equipment Gross194.2 M255.2 M250.4 M
Slightly volatile
Long Term Debt Total273 M203.7 M385.3 M
Slightly volatile
Capital Surpluse1.7 B1.9 B1.6 B
Slightly volatile
Non Current Liabilities Other171 K180 K27.2 M
Slightly volatile
Deferred Long Term Asset Charges11.9 M13.4 M14.6 M
Slightly volatile
Net Invested Capital1.2 B866.9 M1.5 B
Slightly volatile
Net Working Capital292 M204.8 M518.4 M
Slightly volatile
Capital Stock400 K450 K491.2 K
Slightly volatile
Capital Lease Obligations43.7 M31.9 M64.6 M
Slightly volatile

Avanos Medical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization39.5 M41 M48.4 M
Slightly volatile
Interest Expense15.9 M14 M13.7 M
Pretty Stable
Selling General Administrative284 M286.6 M346.6 M
Slightly volatile
Total Revenue817.2 M619 M1 B
Slightly volatile
Gross Profit359.9 M343.2 M446.6 M
Slightly volatile
Other Operating Expenses738.7 M583 M923.6 M
Slightly volatile
Research Development27.2 M23.6 M32.8 M
Slightly volatile
Cost Of Revenue457.2 M275.9 M576.7 M
Slightly volatile
Total Operating Expenses281.5 M307.2 M346.9 M
Slightly volatile
Non Operating Income Net Other2.1 M1.1 M2.4 M
Pretty Stable
Interest Income4.9 M4.6 M13.8 M
Slightly volatile
Non Recurring379.2 M426.6 M465.6 M
Slightly volatile
Reconciled Depreciation35 M41 M49.6 M
Slightly volatile
Selling And Marketing Expenses265.6 M298.8 M326.1 M
Slightly volatile

Avanos Medical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation12.2 M15.9 M10.9 M
Slightly volatile
Begin Period Cash Flow140.9 M100.9 M121.7 M
Slightly volatile
Depreciation42.5 M41 M51.7 M
Slightly volatile
Capital Expenditures31.2 M16 M37.3 M
Slightly volatile
End Period Cash Flow146.7 M123.9 M126.9 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.580.961.8375
Pretty Stable
Dividend Yield0.260.290.3159
Slightly volatile
PTB Ratio1.421.021.2376
Very volatile
Days Sales Outstanding60.7663.4370.0662
Slightly volatile
Book Value Per Share31.4820.7130.156
Slightly volatile
Stock Based Compensation To Revenue0.01150.01810.0137
Slightly volatile
Capex To Depreciation0.810.450.7315
Slightly volatile
PB Ratio1.421.021.2376
Very volatile
EV To Sales1.791.042.0148
Pretty Stable
Inventory Turnover2.762.542.6492
Slightly volatile
Days Of Inventory On Hand135149158
Slightly volatile
Payables Turnover5.686.495.904
Slightly volatile
Research And Ddevelopement To Revenue0.03230.03430.0383
Slightly volatile
Capex To Revenue0.04520.02980.0397
Very volatile
Cash Per Share2.422.112.7008
Pretty Stable
Payout Ratio20.0722.5824.649
Slightly volatile
Days Payables Outstanding81.7258.290.406
Pretty Stable
Intangibles To Total Assets0.620.570.5753
Pretty Stable
Current Ratio1.922.132.2668
Slightly volatile
Receivables Turnover5.935.965.9005
Slightly volatile
Shareholders Equity Per Share31.4820.7130.156
Slightly volatile
Debt To Equity0.290.240.2357
Pretty Stable
Capex Per Share0.420.440.7877
Slightly volatile
Revenue Per Share24.0417.1922.5171
Slightly volatile
Interest Debt Per Share7.824.566.3616
Very volatile
Debt To Assets0.130.14750.144
Pretty Stable
Graham Number34.4429.730.5541
Slightly volatile
Operating Cycle196212228
Slightly volatile
Price Book Value Ratio1.421.021.2376
Very volatile
Days Of Payables Outstanding81.7258.290.406
Pretty Stable
Dividend Payout Ratio20.0722.5824.649
Slightly volatile
Company Equity Multiplier1.631.61.4691
Pretty Stable
Long Term Debt To Capitalization0.220.150.2237
Slightly volatile
Total Debt To Capitalization0.210.20.1761
Slightly volatile
Debt Equity Ratio0.290.240.2357
Pretty Stable
Quick Ratio1.281.381.4767
Slightly volatile
Cash Ratio0.470.580.5276
Slightly volatile
Cash Conversion Cycle114154137
Slightly volatile
Days Of Inventory Outstanding135149158
Slightly volatile
Days Of Sales Outstanding60.7663.4370.0662
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.110.741.2984
Pretty Stable
Price To Book Ratio1.421.021.2376
Very volatile
Fixed Asset Turnover4.795.464.535
Pretty Stable
Debt Ratio0.130.14750.144
Pretty Stable
Price Sales Ratio1.580.961.8375
Pretty Stable
Asset Turnover0.540.690.5243
Slightly volatile
Gross Profit Margin0.380.50.4717
Slightly volatile
Price Fair Value1.421.021.2376
Very volatile

Avanos Medical Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1.4 B1.4 B1.6 B
Pretty Stable
Enterprise Value2.3 B2 B2 B
Pretty Stable

Avanos Fundamental Market Drivers

Avanos Upcoming Events

20th of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Avanos Medical Financial Statements

Avanos Medical shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Avanos Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Avanos Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Avanos Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue-3.5 M-3.3 M
Total Revenue619 M817.2 M
Cost Of Revenue275.9 M457.2 M
Stock Based Compensation To Revenue 0.02  0.01 
Research And Ddevelopement To Revenue 0.03  0.03 
Capex To Revenue 0.03  0.05 
Revenue Per Share 17.19  24.04 
Ebit Per Revenue 0.07  0.08 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Avanos Stock Analysis

When running Avanos Medical's price analysis, check to measure Avanos Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avanos Medical is operating at the current time. Most of Avanos Medical's value examination focuses on studying past and present price action to predict the probability of Avanos Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avanos Medical's price. Additionally, you may evaluate how the addition of Avanos Medical to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY